NICE rules against new hormone therapy combo for breast cancer

Draft guidance on ribociclib with fluvestrant under consultation Related items fromOnMedica NICE rejects adjuvant use of breast cancer drug Breast cancer deaths down due to screening and new therapies New breast cancer drug ‘unaffordable’ for NHS Red tape delaying availability of new cancer drugs One in 10 children in phase I cancer trials respond to drugs
Source: OnMedica Latest News - Category: UK Health Source Type: news